170 related articles for article (PubMed ID: 17916745)
1. The factor VIII C1 domain contributes to platelet binding.
Hsu TC; Pratt KP; Thompson AR
Blood; 2008 Jan; 111(1):200-8. PubMed ID: 17916745
[TBL] [Abstract][Full Text] [Related]
2. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
4. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
Wakabayashi H; Fay PJ
J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
[TBL] [Abstract][Full Text] [Related]
5. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
Ahmad SS; Walsh PN
Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
[TBL] [Abstract][Full Text] [Related]
6. Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.
Gilbert GE; Novakovic VA; Shi J; Rasmussen J; Pipe SW
Blood; 2015 Sep; 126(10):1237-44. PubMed ID: 26162408
[TBL] [Abstract][Full Text] [Related]
7. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
8. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
Saenko EL; Shima M; Gilbert GE; Scandella D
J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
[TBL] [Abstract][Full Text] [Related]
9. The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets.
Suzuki H; Shima M; Kamisue S; Nakai H; Nogami K; Shibata M; Morichika S; Tanaka I; Giddings JC; Yoshioka A
Thromb Res; 1998 Jun; 90(5):207-14. PubMed ID: 9694242
[TBL] [Abstract][Full Text] [Related]
10. Role of factor VIII C2 domain in factor VIII binding to factor Xa.
Nogami K; Shima M; Hosokawa K; Suzuki T; Koide T; Saenko EL; Scandella D; Shibata M; Kamisue S; Tanaka I; Yoshioka A
J Biol Chem; 1999 Oct; 274(43):31000-7. PubMed ID: 10521497
[TBL] [Abstract][Full Text] [Related]
11. Membrane-binding properties of the Factor VIII C2 domain.
Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE
Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768
[TBL] [Abstract][Full Text] [Related]
12. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
[TBL] [Abstract][Full Text] [Related]
13. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
Saenko EL; Scandella D
J Biol Chem; 1997 Jul; 272(29):18007-14. PubMed ID: 9218428
[TBL] [Abstract][Full Text] [Related]
14. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
[TBL] [Abstract][Full Text] [Related]
15. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
[TBL] [Abstract][Full Text] [Related]
16. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.
Stoilova-McPhie S; Villoutreix BO; Mertens K; Kemball-Cook G; Holzenburg A
Blood; 2002 Feb; 99(4):1215-23. PubMed ID: 11830468
[TBL] [Abstract][Full Text] [Related]
17. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived microparticles express high affinity receptors for factor VIII.
Gilbert GE; Sims PJ; Wiedmer T; Furie B; Furie BC; Shattil SJ
J Biol Chem; 1991 Sep; 266(26):17261-8. PubMed ID: 1654328
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.
Meems H; Meijer AB; Cullinan DB; Mertens K; Gilbert GE
Blood; 2009 Oct; 114(18):3938-46. PubMed ID: 19687511
[TBL] [Abstract][Full Text] [Related]
20. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
Zhong D; Saenko EL; Shima M; Felch M; Scandella D
Blood; 1998 Jul; 92(1):136-42. PubMed ID: 9639509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
